Mp-MRI has moderate specificity for the diagnosis of prostate cancer, resulting in many false positive results and unnecessary biopsies for patients with other prostatic diseases. This work presents an approach using VERDICT-MRI to investigate differences in microstructural parameter estimates between normal prostate tissue, false positive lesions and clinically-significant cancer. The VERDICT intracellular volume fraction and intrinsic diffusivity in the extracellular-extravascular space can discriminate false positive lesions with greater accuracy than the clinical ADC from mp-MRI. These results show VERDICT has the potential to identify false positives and reduce unnecessary biopsies in prostate patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords